The Discounted Cash Flow (DCF) valuation of Biomed Lublin Wytwornia Surowic i Szczepionek SA (BML.WA) is 2.66 PLN. With the latest stock price at 5.20 PLN, the upside of Biomed Lublin Wytwornia Surowic i Szczepionek SA based on DCF is -48.8%.
Based on the latest price of 5.20 PLN and our DCF valuation, Biomed Lublin Wytwornia Surowic i Szczepionek SA (BML.WA) is a sell. selling BML.WA stocks now will result in a potential gain of 48.8%.
| Range | Selected | |
| WACC / Discount Rate | 9.4% - 11.7% | 10.5% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 2.18 - 3.53 | 2.66 |
| Upside | -58.1% - -32.2% | -48.8% |